MIF and cancer: PEITC covalently modified MIF (macrophage Migration Inhibitory Factor), making it unsuitable for antibody binding during inflammatory processes, which made authors propose employment of PEITC as MIF inhibitor to tackle cancers and other inflammatory diseases [273].